Total medical devices industry venture financing deals in Q1 2020 worth $2.27bn were announced in the US, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 15.6% over the previous quarter and a rise of 28.7% when compared with the last four-quarter average of $1.76bn.
The US held a 75.9% share of the global medical devices industry venture financing deal value that totalled $2.99bn in Q1 2020.
In terms of deal activity, the US recorded 163 deals during Q1 2020, marking a drop of 9.9% over the previous quarter and a drop of 13.3% over the last four-quarter average.
The US medical devices industry venture financing deals in Q1 2020: Top deals
The top five medical devices industry venture financing deals accounted for 30.5% of the overall value during Q1 2020.
The combined value of the top five medical devices venture financing deals stood at $692.86m, against the overall value of $2.27bn recorded for the month.
The top five medical devices industry deals of Q1 2020 tracked by GlobalData were:
1) General Catalyst Partners, HBM Healthcare Investments, Khosla Ventures, Lightspeed Management Company and SoftBank Vision Fund’s $165m venture financing of Karius
2) The $150m venture financing of Concerto HealthAI by AllianceBernstein Venture Fund, Declaration Partners, Maverick Ventures and SymphonyAI Group
3) Cormorant Asset Management, Deerfield ManagementLP, GV Management Co, Invus Opportunities, Qiming Venture Partners USA and Third Rock Ventures’ $145.6m venture financing of Element Science
4) The $125m venture financing of Outset Medical by D1 Capital Partners, Fidelity Management & Research, Partner Fund Management, Perceptive Advisors and T. Rowe Price Group
5) Koch Disruptive Technologies’ venture financing of InSightec for $107.26m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.